The FDA has approved Ctexli for the treatment of cerebrotendinous xanthomatosis (CTX), a rare lipid storage disease, in adults.According to a press release, Ctexli (chenodiol) is the first ...

Hims & Hers, one of the most popular telehealth services in the world, is in danger of losing one of its central revenue sources. The U.S. Food and Drug Administration (FDA) removed semaglutide ...

Hormone pellets are a type of hormone replacement therapy (HRT) sometimes taken for menopause symptom relief. Pros include convenience and improved symptoms, but there are also a few cons to this ...

A two-day meeting aimed at raising awareness among policymakers and public about rare diseases scheduled for the end of the ...

Shortages of Ozempic and Wegovy that have been in place for more than two years have been resolved, as supplies of the ...

Ozempic and Wegovy, the widely popular forms of semaglutide sold to treat diabetes and obesity, have officially been removed ...

Compounding pharmacies producing cheaper semaglutide products have been given notice they will soon have to stop, as the drug ...

The U.S. is in a severe flu season, and antiviral medications such as Tamiflu can help if you get sick—but it's not recommended for everyone. Here's what you need to know about the medication.

The FDA has now resolved the shortages of Novo Nordisk and Eli Lilly’s blockbuster weight-loss drugs, which could spell the ...

Breakfast snack packs sold at Kroger and Meijer stores in Michigan have been recalled, the FDA announced. Here's what to know.

We will continue to offer access to personalized treatments as allowed by law to meet patient needs,” Hims & Hers CEO said.

Blockbuster weight-loss and diabetes drugs Wegovy and Ozempic are no longer in shortage, the US Food and Drug Administration said on Friday.